rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

NANO-X IMAGING LTD -

NNOX · Nasdaq

Health CareMedical DevicesNot moving yetAI

NNOX stood above a rising 150-day average in 0 of the last 52 weekly readings. It is 70.6% below that average now. Medical Devices: 27% of its 181 stocks in an uptrend (−7 points in four weeks); Health Care: 26% (−10 points in four weeks).

Statistics

Rotation
Not moving yet
Weeks in an uptrend
out for 52
Industry in uptrend
27% -7 in 4 wk
Insider buys, 12 months
$370K
Insider sales, 12 months
$2,237
Officials’ trades on record
0
Institutions holding
97 (-25)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 0 of 52 weeks.

20 Apr – 19 Oct
19%29%40%Apr 26Jun 26Jul 26Sep 26Oct 26

Medical Devices: A minority of its stocks are in an uptrend and the share has been slipping. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026
$0$211KNov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months8
Sale orders, 12 months1
Buyers · sellers3 · 1
WhoDidSharesTraded
Erez MeltzerChief Executive Officerbought25,000at $0.4519 Oct 2026filed 20 Oct 2026
Erez MeltzerChief Executive Officerbought10,000at $0.6915 Sep 2026filed 16 Sep 2026
Dan S. SuesskindDirectorbought30,000at $0.7614 Sep 2026filed 15 Sep 2026
Dan S. SuesskindDirectorbought30,000at $0.7514 Sep 2026filed 15 Sep 2026
Erez MeltzerChief Executive Officerbought10,000at $0.7810 Sep 2026filed 14 Sep 2026
Erez MeltzerChief Executive Officerbought9,443at $1.0310 Aug 2026filed 11 Aug 2026
Noga KainanDirectorbought33,000at $0.9028 Jul 2026filed 29 Jul 2026
Erez MeltzerChief Executive Officerbought36,000at $0.9327 Jul 2026filed 28 Jul 2026
Dan S. SuesskindDirectorbought25,000at $0.9427 Jul 2026filed 29 Jul 2026
Dan S. SuesskindDirectorbought25,000at $0.9227 Jul 2026filed 29 Jul 2026
Erez AlroyDirectorsold209at $1.6510 Jun 2026filed 15 Jun 2026
Erez AlroyDirectorsold469at $1.6510 Jun 2026filed 15 Jun 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders97-25 on the quarter
New · exited23 · 49
Reported value$10.7M

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
UBS Group AGadded · filed 13 Aug 20261,477,524$1.7M+128,700+9.5%
ARK Investment Management LLCadded · filed 14 Aug 2026806,614$936K+73,324+10.0%
MARSHALL WACE, LLPnew · filed 13 Aug 2026778,417$903K+778,417
MORGAN STANLEYadded · filed 13 Aug 2026654,808$760K+178,442+37.5%
BlackRock, Inc.reduced · filed 7 Aug 2026596,033$691K-3,222,411−84.4%
AQR CAPITAL MANAGEMENT LLCadded · filed 14 Aug 2026560,599$650K+65,904+13.3%
BANK OF AMERICA CORPreduced · filed 14 Aug 2026456,777$530K-27,551−5.7%
GOLDMAN SACHS GROUP INCreduced · filed 14 Aug 2026348,573$404K-30,372−8.0%
SUSQUEHANNA INTERNATIONAL GROUP, LLPadded · filed 14 Aug 2026325,312$377K+226,154+228.1%
Jain Global LLCnew · filed 14 Aug 2026304,200$353K+304,200
31 Mar 2023 – 30 Jun 2026
80100120Mar 23Dec 23Dec 24Sep 25Jun 26

Everyone who traded it

Erez Meltzer Company insiderChief Executive Officer · last 19 Oct 20265 · 0
Attias Gali Yahav Company insiderChief Corporate Resources · last 14 Oct 20260 · 0
Guy Nathansohn Company insiderChief Financial Officer · last 14 Oct 20260 · 0
sharon saban Company insiderGeneral Manager AI Division · last 14 Oct 20260 · 0
Feler Marina Gofman Company insiderChief Legal Officer · last 13 Oct 20260 · 0
Cohen Tamar Aharon Company insiderEVP & Chief Marketing Officer · last 11 Oct 20260 · 0
James Dara Company insiderGM Source & Services Division · last 11 Oct 20260 · 0
Ofir Koren Company insiderGeneral Manager, ARC Division · last 10 Oct 20260 · 0
Dan S. Suesskind Company insiderDirector · last 14 Sep 20262 · 0
Ran Daniel Company insiderCFO · last 29 Jul 20261 · 0
Noga Kainan Company insiderDirector · last 28 Jul 20261 · 0
Erez Alroy Company insiderDirector · last 10 Jun 20260 · 1

Same industry

RCEL Avita MedicalLeading+100%
HAE HaemoneticsLeading+48%
ATRC AtriCureLeading+47%
HTFL HeartflowLeading+47%

Distance from each stock’s own 150-day average.

Government contracts

No federal award is tied to it.

From its SEC filings

Profit per saleFY 2025 · to 31 Dec 2025-98.2%
Operating profit marginFY 2025 · to 31 Dec 2025-601%
Free cash flow marginFY 2025 · to 31 Dec 2025-346%
Return on capital employedFY 2025 · to 31 Dec 2025-53.9%
Debt to equityFY 2025 · to 31 Dec 20250.02×
Research spendFY 2025 · to 31 Dec 2025148%
Revenue growthFY 2025 · to 31 Dec 202515.4%
Share count trendFY 2025 · to 31 Dec 20259.1%
Cash and equivalentsFY 2025 · to 31 Dec 2025$49.2M
Free cash flowFY 2025 · to 31 Dec 2025−$45.0M

Analyst forecasts

No analyst forecasts yet.